Correlation Between Aridis Pharmaceuticals and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Reviva Pharmaceuticals.
Diversification Opportunities for Aridis Pharmaceuticals and Reviva Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Aridis and Reviva is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aridis Pharmaceuticals and Reviva Pharmaceuticals
Given the investment horizon of 90 days Aridis Pharmaceuticals is expected to under-perform the Reviva Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Aridis Pharmaceuticals is 3.6 times less risky than Reviva Pharmaceuticals. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 100.00 in Reviva Pharmaceuticals Holdings on September 3, 2024 and sell it today you would lose (78.00) from holding Reviva Pharmaceuticals Holdings or give up 78.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 30.3% |
| Values | Daily Returns |
Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Reviva Pharmaceuticals |
Aridis Pharmaceuticals and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aridis Pharmaceuticals and Reviva Pharmaceuticals
The main advantage of trading using opposite Aridis Pharmaceuticals and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |